LS&HC Horizons 2023 - Flipbook - Page 52
52
9
APAC
Life Sciences in Japan
53
Strengthened emphasis on drug and medical device
quality management in China
54
Chinese government’s strengthened enforcement against
misconduct involved in purchase and sales in the
pharmaceutical industry
55
Cell, tissue and gene therapies: regulatory challenges
and responses in Australia
56
Conducting life sciences investigations in Vietnam
57